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Background
T h e r ei sap a u c i t yo fe v i d e n c e - b a s e dd a t af o rt h et r e a t -
ment of primary systemic vasculitis (PSV) in childhood,
partly due to the lack of a standardised outcome-mea-
sure for use in clinical trials. The Paediatric Vasculitis
Activity Score (PVAS) is a quantitative clinical-index of
manifestations of active disease, divided into 9 organ
sub-systems.
Objective
To provide preliminary validation of the PVAS.
Methods
Children at Great Ormond Street Hospital NHS Trust
with a diagnosis of PSV underwent simultaneous assess-
ment of disease activity by 2 assessors. Scores were
assessed for inter-observer variability and correlation
with the physician’s global assessment of disease activity
(PGA), ESR and CRP. Patients with newly diagnosed
PSV were assessed twice: at diagnosis and 1 month, to
assess tool-responsiveness to a change in disease state.
Results
23 children with PSV were studied - 48% male, 52%
female. The diagnoses were: Behçet’s disease (n=7),
Wegener’s granulomatosis (n=5), polyarteritis nodosa
(n=5), cutaneous leukocytoclastic vasculitis (n=3),
Cogan’s syndrome (n=1), microscopic polyangiitis (n=1)
and unclassified vasculitis (n=1). Median PVAS was 1.5
(range 0-38). Bland-Altman analysis demonstrated high
inter-observer agreement and Kappa analysis showed
perfect agreement for 8/9 organ-system scores (K=1,
p=0.00). Spearman’s rank showed correlation between
PVAS and PGA (rs=0.87, 95%CI=0.71 to 0.94, p=0.00)
and CRP (rs=0.54, 95%CI=0.10 to 0.81, p=0.02) but no
correlation with ESR (rs= -0.1). Four newly diagnosed
patients demonstrated a fall in the PVAS in response to
therapy (change in median from 13.5/63 to 3.5/63), with
good agreement for this change between assessors.
Conclusion
This study provides preliminary evidence that PVAS is a
useful clinical measure of vasculitis disease-activity with
good inter-observer reliability and correlates highly with
the PGA and CRP.
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